hotspot -WSS

hotspot

author：Wikipedia 2025-09-05 13:47:32 - browse：8961

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Fetal cell organoids grown from amniotic fluid, study finds

WSS

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Harvard's David Sinclair gets blowback over aging

The public health thinking behind the CDC’s new Covid guidance

Why Talkspace is targeting Medicare, a tricky market

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

explore

hotspot

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

First over

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Immune cells and nerve overgrowth may explain recurring UTI pain

At least 13 dead in Texas as scorching temps continue

Sage considers ways to reduce costs following FDA rejection

United colonoscopy coverage change 'may cost lives,' doctors say

Restaurant meals are packed with calories, and we still keep eating them

Medical records are filled with copy

Feed a cold, starve a fever? Here’s what science says

hotspot

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Immune cells and nerve overgrowth may explain recurring UTI pain

Ozempic has benefits for kidney disease as well as diabetes

Ancient Greek ideas underpin modern concepts of pregnancy

Fetal cell organoids grown from amniotic fluid, study finds

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

leisure time

focus

focus

focus